Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Free Cash Flow
Sedana Medical AB (publ)
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Free Cash Flow
-kr186.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Free Cash Flow
kr817m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Free Cash Flow
kr89.7m
|
CAGR 3-Years
54%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Free Cash Flow
kr120.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
17%
|
|
|
Getinge AB
STO:GETI B
|
Free Cash Flow
kr3.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Free Cash Flow
kr1.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Free Cash Flow?
Free Cash Flow
-186.8m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Free Cash Flow amounts to -186.8m SEK.
What is Sedana Medical AB (publ)'s Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-24%
Over the last year, the Free Cash Flow growth was 10%. The average annual Free Cash Flow growth rates for Sedana Medical AB (publ) have been -7% over the past three years , -24% over the past five years .
You don't have any saved screeners yet